This letter describes a woman with recurrent episodes of acute kidney injury due to oxalate nephropathy after hair-straightening procedures and provides evidence that glyoxylic acid is responsible.
The coronavirus disease 2019 (Covid-19) pandemic has highlighted the crucial role of randomized trials in guiding clinical practice and the need for designs that provide rapid evaluation of ...
Maternal use of valproate during pregnancy has been associated with an increased risk of neurodevelopmental disorders in children. Although most studies of other antiseizure medications have not shown ...
The Working Group reviewed and evaluated the evidence relative to the efficacy and effectiveness of screening by conventional cytology, liquid-based cytology, visual inspection with acetic acid ...
The Food and Drug Administration (FDA) recently approved pembrolizumab, a programmed death 1 (PD-1) blocking antibody, for patients who have treatment-refractory cancers with a tumor mutational ...
Gregory L. Fricchione, M.D., Aaron B. Paul, M.D., Zeina Chemali, M.D., M.P.H., and Michael D. Kritzer, M.D., Ph.D. Dr. Michael D. Kritzer: A 57-year-old woman with ...
The polarizing nature of vaccination against coronavirus disease 2019 (Covid-19) within the United States threatens public health and has contributed to variable statewide vaccine uptake that ...
Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services.
The ethical principles of beneficence and respect for patients as whole persons may require doctors to inquire about patients’ spiritual and religious needs and refer them to a chaplain as ...
To the Editor: In their phase 3 trial, Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF), Teerlink et al. (Jan. 14 issue) 1 ...
Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. In this trial, we assessed whether omalizumab, a ...